FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Teleflex Incorporated Stock AnalysisComprehensive stock analysis for Teleflex Incorporated (TFX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTFX
TFX
Teleflex Incorporated
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TFX
Home🔹Stocks🔹Teleflex Incorporated

Teleflex Incorporated

🇺🇸TFX•NYSE

Teleflex Incorporated

🇺🇸TFX•NYSE
Market cap
$5.80B
Sentiment

Your view on TFX

Mkt Cap
$5.80B
Sentiment
Your view
TFX
Teleflex Incorporated
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TFX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Teleflex Incorporated

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Liam J. Kelly
Headquarters
550 East Swedesford Road, Wayne, PA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Liam J. Kelly
Headquarters
550 East Swedesford Road, Wayne, PA, US
Description

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.

It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments.

The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings.

It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets.

The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Teleflex Incorporated, and the rating behind it. TFX last traded at $130.99; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Teleflex Incorporated. Starting points for Teleflex Incorporated: EPS -$23.63, beta 0.81 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Teleflex Incorporated. Teleflex Incorporated paid $1.36 per share over the last year — a 1.0% yield at the current $130.99 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Teleflex Incorporated. Trailing twelve-month EPS for Teleflex Incorporated stands at -$23.63. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Teleflex Incorporated. Teleflex Incorporated has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Teleflex Incorporated valued side by side against its closest peers. Teleflex Incorporated is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Teleflex Incorporated, and how their positions are changing. At a $5.80B market value, institutional positions materially move Teleflex Incorporated's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Teleflex Incorporated executives and directors. Shares of Teleflex Incorporated have traded between $102.58 and $195.42 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Teleflex Incorporated. Teleflex Incorporated is a $5.80B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Teleflex Incorporated. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Teleflex Incorporated. Coverage tracks Teleflex Incorporated within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ALKS — Alkermes plc
  • ARWR — Arrowhead Pharmaceuticals, Inc.
  • BLCO — Bausch + Lomb Corporation
  • CRSP — CRISPR Therapeutics AG
  • KRYS — Krystal Biotech, Inc.
  • MMSI — Merit Medical Systems, Inc.
  • PCVX — Vaxcyte, Inc.
  • PTCT — PTC Therapeutics, Inc.

More Medical - Instruments & Supplies companies

  • YBGJ — Yubo International Biotech Limited
  • ZJYL — Jin Medical International Ltd.
  • SHWGY — Shandong Weigao Group Medical Polymer Company Limited
  • SMTI — Sanara MedTech Inc.
  • SOAGY — Sartorius AG
  • SOLV — Solventum Corporation
  • SRTOY — Sartorius Stedim Biotech S.A.
  • SSSGY — Sartorius AG
  • STAA — STAAR Surgical Company
  • STSS — Sharps Technology, Inc.
  • STVN — Stevanato Group S.p.A.
  • STXS — Stereotaxis, Inc.

ETFs holding Teleflex Incorporated

  • PSCH — Invesco S&P SmallCap Health Care ETF (3.06%)
  • MDEV — First Trust Indxx Medical Devices ETF (2.17%)
  • BSMC — Brandes U.S. Small-Mid Cap Value ETF (1.65%)
  • XHE — State Street SPDR S&P Health Care Equipment ETF (1.56%)
  • IHI — iShares US Medical Devices ETF (0.89%)
  • GSC — Goldman Sachs Small Cap Equity ETF (0.83%)
  • VIOV — Vanguard S&P Small-Cap 600 Value ETF (0.65%)
  • SLYV — State Street SPDR S&P 600 Small Cap Value ETF (0.64%)

News

Latest Market News